Cayman Chemical and Akadeum Partner to Accelerate Cell & Gene Therapy Research

Strengthening Support for Cell and Gene Therapy Development

Cayman Chemical has partnered with Akadeum Life Sciences to strengthen research support for the fast-growing cell and gene therapy field. The collaboration combines Cayman’s biochemical reagent expertise with Akadeum’s microbubble-based cell isolation technology. Together, they aim to improve research workflows, enhance cell processing, and accelerate therapeutic development.

Expanding Capabilities With Complementary Technologies

Akadeum’s microbubble technology will be integrated with Cayman Chemical’s products used in bioprocessing, immunology, and cell biology. The microbubbles enable gentle and efficient separation of specific cell types without damaging sensitive samples. When combined with Cayman’s reagents, researchers can achieve higher-quality cell preparations for downstream applications.

Benefits for Cell Therapy Researchers

Cell isolation is a critical step in many therapy workflows, especially when scaling from research to clinical production. The combined solution helps reduce processing time, improve cell viability, and increase yield. This supports both academic and industry teams working with rare or delicate cell populations.

Driving Innovation and Workflow Efficiency

By aligning their technologies, Cayman Chemical and Akadeum offer researchers more streamlined and reliable workflows. Integrated solutions help minimize sample loss, reduce manual handling, and improve data consistency. This allows projects to move more efficiently from discovery to preclinical development.

Key Highlights

• Microbubble cell isolation combined with biochemical reagents

• Improved handling of delicate and rare cells

• Higher viability and yield for downstream use

• Supports immunology, gene editing, and bioprocessing

Applications

• Cell and gene therapy research

• Immune cell isolation

• Functional assays and profiling

• Bioprocess optimization

• Preclinical studies

Enabling Next-Generation Research

This partnership reflects the evolving needs of the cell and gene therapy community. By simplifying complex workflows and improving cell handling, Cayman Chemical and Akadeum help researchers focus on innovation and therapeutic progress.